Medifast Inc.’s fourth quarter earnings were down, capping off a year of decline that the company thinks will continue into 2023. The Baltimore weight loss firm’s revenue declined from $377.83 million in the fourth quarter of 2021 to $377.25 million in the fourth quarter of 2022. The company reported profits of $26.5 million or $2.43 per share, compared to $34 million or $2.93 per share in the year-ago period, a 22% drop in profits.
Medifast’s Q4 revenue declines as CEO predicts losses will continue in 2023
February 23, 2023
